Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

O. Nuri Ozgirgin

O. Nuri Ozgirgin

Proffessor Bayindir Hospital Turkey

Cristina Vittoria Dieni

Cristina Vittoria Dieni

University of Perugia Italy

Kailash N Pandey

Kailash N Pandey

Tulane University USA

Stephanie C Joachim

Stephanie C Joachim

University Eye Hospital Germany

Marina Zueva

Marina Zueva

Moscow Helmholtz Research Institute of Eye Diseases Russia

Maria Lindau

Maria Lindau

Stockholm University Sweden

Keith Pennypacker

Keith Pennypacker

University of Kentucky USA

Nachum Dafny

Nachum Dafny

The University of Texas USA

Neurochemistry Congress 2018

About Neurochemistry & Neuropharmacology Conference

Neurochemistry Congress 2018

Neurochemistry Congress 2018 invites all the participants from all over the world to attend 25th International Conference on Neurochemistry and Neuropharmacology during September 17-18, 2018 in Dubai, UAE. which includes prompt keynote presentations, Oral talks, Poster presentations, Workshops and Exhibitions.

Why to attend???

With members from around the world focused on learning about neuropharmacology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neurochemistry & Neuropharmacology community conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neurochemistry & Neuropharmacology are hallmarks of this conference.

      Target Audience:

  • Neurologists
  • Neuro Surgeons
  • Neurochemistry Students
  • Neurochemistry Scientists
  • Neurochemistry Researchers
  • Neurochemistry  Faculty
  • Medical Colleges
  • Neurochemistry Associations and Societies
  • Manufacturing Medical Devices Companies
  • Neuropharmacology Students
  • Neuropharmacology Scientists
  • Neuropharmacology Researchers
  • Neuropharmacology Faculty
  • Neuropharmacology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes

2018 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings


Highlights of latest advances on Neurochemistry and Neuropharmacology 2018

Track 1: Neurochemistry

Neurochemistry deals with the processes happening in nervous system and nerve tissues. One of these processes is Neurotransmission, wherein, the interaction at the synapse occurs with the help of neurotransmitters such as Dopamine, Acetylcholine, Norepinephrine, Glutamate,  Serotonin, Gamma-aminobutyric acid (GABA), Endogenous opioids etc. The activity of ion channels assists neurotransmitter receptors to receive the signals. This mechanism is altered by the many drugs, as a treatment process of neurological disorders.

The global sales of drugs to treat progressive dementia with other neurological abnormalities expected to reach $537.2 million in 2012 and $913.7 million by 2017, at a CAGR of 11.2% over the five-year forecast period. These are the chemicals introduced into the Photoswitchable ligands into ion channels stirrups the possible ways of diverse roles of neurotransmitters and receptors in the nervous system.

Track 2: Neuropharmacology

The neuropharmacology will discuss the drug-induced changes in functioning of the nervous system. The specific focus of this course will be to provide a description of the cellular and molecular actions of drugs on synaptic transmission. This course will also refer to specific diseases of the nervous system and their treatment in addition to giving an overview of the techniques used for the study of neuropharmacology.

Track 3: Neuroscience

The human brain remains a great mystery in science and current research strives to understand molecular and cellular processes of the nervous system. Prevention and effective treatment of neurological disorders like Alzheimer's and Parkinson's diseases has been a major medical challenge. Neurology is the enclosure of medical research and practices that devoirs disorders and issues of the nervous system, including the brain. Doctors specialized in diagnosing patients and their problems whereas neurology nurses are one who trained to aid these doctors in the treatment of patients with neurological issues. Neurology nurse deals with giving both post-operative care and immediate care. Various conditions Like Parkinson’s disease, brain tumours, encephalitis, multiple sclerosis and meningitis, as well as those who have suffered from trauma, such as neurology victims and those who have had spinal or brain

Track 4: Neurosurgery

Neurosurgery is the surgical specialization that treats diseases and disorders of the brain and spinal cord. Back pain can sometimes produce neurological symptoms such as numbness, muscle weakness, and loss of bowel and bladder control due to dysfunction at the nerve root.

These symptoms are indicators that neurosurgery is required to treat the underlying cause of back pain as opposed to conservative treatments. Procedures to treat back pain under the realm of neurosurgery include discectomy, laminectomy, and spinal fusion surgery.

In Neurosurgery, there is a higher risk of further nerve damage and infection which may result in paralysis.

In Neurosurgery, there is a higher risk of further nerve damage and infection which may result in paralysis.

Track 5: Neurological & Neurosurgical Nursing

Nursing is a very challenging specialty that deals with assessment and management of many neurological disorders. Mostly the Neuroscience Nursing professionals assist patients with   nervous system and brain disorders. Some of their responsibilities include administering medication, monitoring neurological exams, consulting physicians on patient progress etc. Basically the nurses provide patient care for Neurological complications like trauma, strokebrain injuries, headaches, seizures, infections and aneurysms etc.

Track 6: Neuro oncology

The Central Nervous System is denounced to various Malevolent disordersCentral Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, Neurons and Sensory Receptors, Neurological Disorders, Neurodegenerative disease and Imaging agents to CNS neurofibroma. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures.

Global Central Nervous System Drugs market to grow at a CAGR of -3.2% over the period 2011-2015. The global central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, the introduction of new drugs, and increased outgo on healthcare.

Track 7: Neuroimaging in Psychiatry

Neuroimaging is the mapping of the human brain using functional Magnetic Resonance Imaging (fMRI). Neuroimaging determines the association between Environmental factors and health influence on Brain ageing throughout the adult lifespan. It determines how difference and change in Cerebral structure, complexly relates to Behavior and Cognition at Multiple levels of Analysis

It brings together various topics of interests such as Functional Neuroimaging, , Neuropsychology and Cognitive Neuroscience, Computational Modeling

Track 8: Neuroinformatics

Neuroinformatics is an examination field worried with the association of neuroscience information by the use of computational models and explanatory apparatuses. These territories of research are critical for the coordination and investigation of progressively extensive volume, high-dimensional, and fine-grain exploratory information. Neuroinformaticians give computational instruments, scientific models, and make interoperable databases for clinicians and research researchers. Neuroscience is a heterogeneous field, comprising of numerous and different sub-disciplines (e.g., Cognitive Psychology, behavioral neuroscience, and behavioral hereditary qualities). All together for our comprehension of the mind to keep on deepening, it is fundamental that these sub-orders can share information and discoveries, definitively Neuroinformaticians encourage this Neuroinformatics remains at the convergence of neuroscience and data science. 

Computational Neuroscience

Neural Computation


Brain Informatics

Analysis and modeling of CNS and neuronal system

Track 9: Stroke & Neurological Disorders

stroke is a restorative crisis. stroke happens when bloodstream to your mind stops. Inside minutes, cerebrum cells start to kick the bucket. There are two sorts of stroke. The more normal kind, called ischemic stroke, is created by a blood coagulation that squares or attachments a vein in the cerebrum. The other kind, called hemorrhagic stroke, is brought on by a vein that breaks and seeps into the cerebrum. "Smaller than normal strokes" or transient ischemic assaults (TIAs), happen when the blood supply to the cerebrum has quickly interfered. Stroke is the third driving reason for death in the United States. Of the more than 700,000 individuals influenced each year, around 500,000 of these are first assaults, and 200,000 are intermittent. Around 25 percent of individuals who recuperate from their first stroke will have another stroke inside five years. Stroke is the main source of genuine long haul handicap, with an expected 5.4 million stroke survivors presently alive today. The American Heart Association assesses that in 2003, stroke cost

Track 10: Heart and Brain

Most of us have been taught in school that the heart is constantly responding to “orders” sent by the brain in the form of neural signals. However, it is not as commonly known that the heart actually sends more signals to the brain than the brain sends to the heart! Moreover, these heart signals have a significant effect on brain function—influencing emotional processing as well as higher cognitive faculties such as attention, perception, memory, and problem-solving. In other words, not only does the heart respond to the brain, but the brain continuously responds to the heart.

The effect of heart activity on brain function has been researched extensively over about the past 40 years. Earlier research mainly examined the effects of heart activity occurring on a very short time scale—over several consecutive heartbeats at maximum. Scientists at the HeartMath Institute have extended this body of scientific research by looking at how larger-scale patterns of heart activity affect the brain’s functioning.

Track 11: Neuro Immunology

Neuroimmunology refers to the interdisciplinary field merging neurology, immunology, and aspects of neuroscience. It is a scientific and clinical domain. Scientifically, neuroimmunology tries to understand the bidirectional links between the nervous and immune systems, and their implications to illnesses. Multiple Sclerosis and Related Disorders is a priceless expansion to the writing and will be of critical enthusiasm to neurologists, inhabitants and colleagues, internists, and general professionals who treat patients having neurologic issue and other systemic immune system illnesses.

Track 12: Neurological Nursing

Nursing is a very challenging specialty that deals with assessment and management of many neurological disorders. Mostly the Neuroscience Nursing professionals assists patients with   nervous system and brain disorders. Some of their responsibilities include administering medication, monitoring neurological exams, consulting physicians on patient progress etc. Basically the  nurses provide patient care for Neurological complications like strokebrain injuries, headaches, seizures, infections and a aneurysms etc.

Track 13: Computational Neurology

Computational neuroscience is the study of brain function in terms of the information processing properties of the structures that make up the nervous system. It is an interdisciplinary science that links the diverse fields of neuroscience, cognitive science, and psychology with electrical engineering, computer science, mathematics and physics.

Computational neuroscience is distinct from psychological connectionism and machine learning in that it emphasizes descriptions of functional and biologically realistic neurons (and neural systems) and their physiology and dynamics. These models capture the essential features of the biological system at multiple spatial-temporal scales, from membrane currents, protein and chemical coupling to network oscillations, columnar and topographic architecture and learning and memory.

These computational models are used to frame hypotheses that can be directly tested by current or future biological and/or psychological experiments.

Track 14: Clinical Interventions & Case Reports

Recent clinical studies have shown that between half-hour and hour of drug abusers have mental state diagnoses Depression, schizophrenic psychosis, and manic disorders. Drug addiction may be typical of  disorder involves the interaction of environmental factors and genetic factors to extend the susceptibility of an individual to addictive behavior. SAMHA scientist’s area unit working on the pharmacological and neuropsychoslogical models and approaches that involve pre-symptomatic studies and clinical findings, to elucidate the results of mental health and physical disorders and outcomes in drug-addicts, Researchers specialize in pregnant women smokes cigarettes. Tobacco usage elevates therapeutic and behavioral therapies in smokers with synchronous psychiatrically disorders

Track 15:  Neurotransmitters

These are the brain chemicals that connect the brain and the body.  They transmit signals between nerve cells, called neurons. They can also affect mood, sleep, concentration, weight, and can cause adverse symptoms when they are out of balance. These are of two types: Inhibitory and Excitatory. Acetylcholine, Glutamine, and GABA are some of these neurotransmitters.



Cleveland Clinic | St Jude Children's Research Hospital | Johns Hopkins Medicine | Mayo Clinic Scottsdale AZ | University of Maryland Medical Center | M D Anderson Cancer Center | Massachusetts General Hospital | Memorial Sloan Kettering Cancer Center | New York Presbyterian | Lower Manhattan Hospital | Providence Health & Services | Deer's Head Hospital Center | Beth Israel Deaconess Medical Center Needham | Aurora Health Care | Advocate Health Care | University of Pittsburgh Medical Center | Brigham and Women's Hospital | (1) Hartford Hospital | INCA Instituto Nacional de Câncer | Alberta Health Services | Tricare Military Health System | Children's Hospital of Philadelphia | H Lee Moffitt Cancer Center & Research Institute | Navy Medicine| Children's Mercy Hospitals and Clinics | Arizona State Hospital | Kaiser Permanente CA | University of North Carolina Healthcare | University of Wisconsin Health | Seattle Children's Hospital and Medical Center | University of Chicago Hospitals | Children's Hospital Boston | Society of Cardiovascular and Interventional Radiology | (1) University of Virginia Health System | Texas Health Resources Inc. | Cincinnati Children's Hospital Medical Center | Hospital Israelita Albert Einstein | Northwestern Medicine | Ochsner Health System | Mount Sinai Medical Center New York |University of Utah Health Care| Lahey Clinic|Group Health Cooperative Health Care System Seattle| Carolinas Healthcare System| Henry Ford Hospital| UCLA University of California Los Angeles Health System CA| Hospital Italiano de Buenos Aires| Children's Healthcare of Atlanta Pediatric Hospital| Hospital El Cruce| Inova Health System Northern Virginia| Banner Health| Indiana University Health Bloomington| Hospital for Special Surgery| Sanford Health (Union Hospital Mayville North Dakota)|Hospital for Sick Children| Dana Farber Cancer Institute Boston MA|Scott and White Memorial Hospital| Allina Health| MedStar Health| Santé Montérégie| Scripps Health System San Diego|Centre for Addiction & Mental Health| Cedars Sinai Medical Center


Market Analysis

Neurochemistry Congress 2017 welcomes attendees, presenters, and exhibitors from all over the world to Dubai ,UAE .We are delighted to invite you all to attend and register for the 25th International Conference on Neurochemistry and Neuropharmacology which is going to be held September 24-25,2018 in Dubai,UAE. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neurochemistry Congress 2018 where you will be sure to have a meaningful experience with scholars from around the world. All the members of Neurochemistry and Neuropharmacology 2018 organizing committee look forward to meet you at Dubai,UAE

For more details please visit-

Importance and Scope Neurochemistry and Neuropharmacology is the study of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behaviour. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, cotransporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more.

It is necessary to focus Neurochemistry and Neuropharmacology and the use of neuropharmaceuticals to transform brain processes in the way of enhancing memory, mood, sensation, thinking and attention in people.

Comparative analysis for Neurological Disorders (Age wise profile)

Conference Highlights





Neurological & Neurosurgical Nursing

Neuro oncology

Neuroimaging in Psychiatry


Stroke & Neurological Disorders

Heart and Brain

Neuro Immunology

Neurological Nursing

Computational Neurology

Clinical Interventions & Case Reports

Hospitals of Neuropharmacology

Mayo Clinic, Rochester, Minnesota

Johns Hopkins Hospital, Baltimore, Maryland

Massachusetts General Hospital, Boston

University of California–San Francisco Medical Center

Mathodist Hospital, San Antonio

University of California–Los Angeles Medical Center

New York University Langone Medical Center, New York City

Hospitals of the University of Pennsylvania–Penn Presbyterian

Northwestern Memorial Hospital, Chicago

Baptist Medical Centre, San Antonio

Major Neurochemistry and Neuropharmacology Associations related around the Globe

ERA NET Neuran

Volkswagon Stifung Foundation

American National Science and Education Fund

Vienna science and Technology fund

Snota Restaviel National Science Foundation


Massachusetts General Hospital Bost

Duras Neuroscience Center Florida

UCLLA Brain Research Institute California

ASN, American Society for Neurochemistry

International Society for Neurochemistry (ISN)

European neurochemistry society

Asian-Pacific Society for Neurochemistry

Canadian Neurological Sciences Federation

European Parkinson’s disease Association

Malaysian Society of Neurosciences

Eurospine, The Spine Society Of Europe

The Spanish Society of Neurology (SEN)

The Czech Neuropsychopharmacological Society

Belgian Neurological Society

National Neurotrauma Society

National Parkinson'S Foundation

European Society Of Neurosonology And Cerebral Hemodynamics

Federation Of European Neuroscience Societies

Malaysian Society Of Neurosciences

Česká Neurologická Společnost

The Czech Neuropsychopharmacological Society

European Academy Of Neurology

Deutsche Gesellschaft Fur Neurologieologie

International Brain Research Organization

The Neuropathy Association

The Primary Care Neurology Society

The Spanish Society Of Neurology (SEN)

Major Neuropharmacology related Associations

International Neuroethics Society

Society for Behavioral Neuroendocrinology

Society For Neuroscience

American Psychological Association

International Parkinson and Movement Disorder Society

American Neurological Association

National Institute Of Environmental Health Sciences

The American Society of Neuroimaging

American Board Of Psychiatry And Neurology, Inc.

American Clinical Neurophysiology Society

International Neuropsychological Society

Southern Clinical Neurological Society

International Parkinson And Movement Disorder Society

Products for Neurological Treatments

This above statistic displays the global revenue of Abilify from Bristol-Myers Squibb from 2011 to 2014. In the United States alone, Abilify generated a revenue of 2.1 million U.S. dollars in 2012. Abilify is an antipsychotic agent that is used to treat various conditions such as schizophrenia, bipolar mania disorder, and major depressive disorder.

Gross Profit Margin of Neuropharmaceutical related companies

Market Capitalization of Neuropharmaceutical companies: In 2014, investors provided $3.3 billion into firms that are developing drugs for brain-destroying or psychiatric illnesses. Some big drug companies, including Johnson & Johnson, Roche and Novartis, are finding ways to reinvigorate their efforts. New medicines for severe depression, psychosis and schizophrenia could reach the market within the next few years, and treatments for Alzheimer’s, Parkinson’s and some forms of autism are a real possibility, too.

Sales Profile of Neuropharmaceutical companies

Research Fund: NIH (National Institute of Health) and NSFC (Nature Science Foundation of China) provided fund for the neurological disorders such as dementia, schizophrenia, stroke, parkinson’s, epilepsy.

Institutes funding for research

1)      The US National Institutes of Health fund a Neuropharmacology Laboratory project, Universitat Pompeu Fabra, Barcelona

2)      Neuropharmacology Program, The National Institute of Mental Health (NIMH)

3)      McKnight Endowment Fund for Neuroscience

The statistic depicts the research and development expenditure of the entire pharmaceutical industry of the United States from 1995 to 2014. In 2004, the expenditure of the entire U.S. pharmaceutical industry on research and development came to 47.6 billion U.S. dollars.

Related Conferences

Neuroscience Events | Neurosurgery Meetings | Neurochemistry Conferences | Neuro-Oncology Conferences| Brain conferences | Neurology Workshops

  1. International Conferences on Neurogenetics & Neurodegeneration August 13-14, 2018 Dubai.UAE
  2. International Conferences on Neuroncology & Neurosurgery September 20-21, 2018, Dubai.UAE
  3. World Neurone Diseases Congress September 13-15, 2018 Romania
  4. Neurodegenerative & Neuroinflammation From Discovery to Health October 18-20, 2018, Finland
  5. International Conferences on Psychiatry & Mental Health  October 11-13, 2018, Dubai.UAE
  6. Annual Conferences on Dementia & Alzheimer's Disease December 13-15, 2018 Abu Dubai.UAE
  7. World Brain  Congress  December 05-07, 2018 Dubai.UAE
  8. 2nd International Nursing Conferences July 19-21, 2018 Dubai.UAE
  9. International Pharmaceutical Chemistry Conferences July 19-21, 2018 Dubai.UAE
  10. 25th World Congress on Neurology & Neuroscience June 18-19, 2018 Dublin, Ireland
  11. 7th International Conferences on Brain and Neurological Disorders April 10-12, 2018 Amsterdam, Netherlands.
  12. 22nd International Conferences on Neurology & Neurophysiology  April 23-24, 2018 Rome, Italy
  13. 24th International Conferences on Neuroscience and Neurochemistry May 21-22, 2018  Birmingham UK
  14. 3rd International Conference on Neuro-Oncology and Brain Tumor  September 14-15, 2018 Singapore.
  15. International Neurology and Brain Disorder Conferences  June 04-06, 2018  Rome, Italy
  16. 23rd  World Neurology (WCN 2017) Congress September 16-21 2017 Kyoto, Japan
  17. 14th Neuro Oncology (ASNO) Meetings October 29-31, 2017  Japan
  18. Neuro-Oncology  Conferences  July 23-27, 2018 Waimea, Hawaii
  19. 23rd International Conference on Neurology and Neurosurgery April 23-24, 2018 Rome, Italy
  20. World Summit on Neurology & Neuroscience September 26-27, 2018 Montreal, Quebec, Canada
  21. 24th International Conference on Neuroscience and Neurochemistry May 21-22, 2018 || Birmingham,UK
  22. 12th Global Meeting on Neurologists and Neurosurgery May 21-22, 2018 Singapore
  23. 22nd International Conference on Neurology & Neurophysiology April 23-24, 2018 Rome, Italy.
  24. 25th World Congress on Neurology and Neurodisorders July 16-17, 2018 Melbourne, Australia
  25. World Summit on Stroke & Neurological Disorders August 31-September 01, 2018 Boston, Massachusetts, USA
  26. 6th International Conference on Brain Disorders and Therapeutics, September 13-15, 2018 Copenhagen, Denmark
  27. 18th Global Neuroscience Conference September 19-20, 2018 Tokyo, Japan
  28. 27th International Conference on Neurology and Cognitive Neuroscience October 18-19, 2018 Warsaw, Poland
  29. International Conference on Brain Disorders and Dementia Care September 21-22, 2018 Philadelphia, Pennsylvania, USA
  30. International Conference on Neuroimmunology, Neurological disorders, and Neurogenetics September 26-27, 2018 Montreal, Canada.

Asia Pacific & Middle East:

Emirates Neurology Society (EMINS)Emirates Nursing Association,Emirates Cardiac Society;Association of Neurophysiological ScientistsOncology Nursing Society ONSIraqi Neurological Association (INA) - Iraq (IQ)Israel Society for Neuroscience - Israel (IL) Society for Arab NeuroscientistsMiddle East Spine SocietyMediterranean Neuroscience SocietyNorth Africa and the Middle East - Society for NeuroscienceThe Pan Arab Neurosurgical SocietyEmergence of Cognitive Neuroscience in The Middle EastMiddle East Neurosurgical SocietyThe Saudi Critical Care Society;  Walter E. Dandy Neurosurgical SocietyPhilippine Neurological Association (PNA)Malaysian Society of NeurosciencesNeurological Society of IndiaNeurological Surgeon Society of India (NSSI)Clinical Neuroscience Society SingaporeThe Hong Kong Neurological Society Neurosurgical Association, MalaysiaThe Japan Stroke SocietyAsian Pacific Society for NeurochemistryIndian Society of Neuro-OncologyIndian Pharmacological Society ;Bahrain Neurosciences Association; Society of Neurologists of Bangladesh;Chinese Neurological Society; The Hong Kong Neurological Society; Indian Academy of Neurology; Indonesian Neurological Association; Iranian Neurological Association; Iraqi Neurological Society; Israel Neurological Association; The Japanese Society of Neurology; The Jordan Neurological Society; League of Neurologists of Kazakhstan; Korean Neurological Association; Kuwait Neurological Society; National Association of Neurologists of the Kyrgyz Republic (NANKR); Lebanese Neurological Society; Malaysian Society of Neurosciences; Mongolian Association of Neurologists; Myanmar Society of Neurology; Pakistan Society of Neurology; Palestinian Neurological Society; Philippine Neurological Association; Qatar Neuroscience Club; Saudi Neurological Society; Clinical Neuroscience Society, Singapore; Association of Sri Lankan Neurologists; Syrian Society of Neurosciences; Taiwan Neurological Society; The Neurological Society of Thailand; Emirates Neurosciences Society; Vietnamese Association of Neurology; Yemeni Neuroscience Society (YNS); Australian and New Zealand Association of Neurologists; "Neurological Association of New Zealand.


American Academy of Neurology; American Association of Neurological Surgeons; The American Centre for Psychiatry and Neurology; American Society of Neuro-rehabilitation, USA; Albanian Alzheimer Society; Canadian Stroke Consortium; The American Centre for Psychiatry and Neurology; The Chinese Stroke Association (CSA); Aneurysm Foundation and Brain Injury Association of America; Brain Aneurysm Foundation& Brain Injury Association of America; Huntington's Disease Society of America and Hydrocephalus AssociationUnited Spinal Association& Vascular Birthmarks Foundation; American Society for Neurochemistry; The Canadian Society of Pharmacology and Therapeutics; American Society for Pharmacology and Experimental Therapeutics; Epilepsy Foundation of America; Parkinson Society Canada; Academy of Neurologic Communication Disorders and Sciences (ANCDS)Acoustic Neuroma Association (ANA) USCanadian Association of Child Neurology (CACN) - Canada (CA)Child Neurology FoundationCanadian Society of Clinical Neurophysiology (CSCN) - Canada (CA)Center for Behavioral Neuroscience (CBN)Brazilian Society of Neuroscience and Behavior ; Canadian Neurological Society; Asociacion Costarricense de Ciencias Neurologicas (ACCN); Instituto de Neurologia y Neurocirugia; Dominican Neurological and Neurosurgical Society; Asociacion de Ciencias Neurologicas de El Salvador; Asociacion Guatemalteca de Neurologia; Asociación Hondureña de Neurología; Academia Mexicana de Neurologia; Asociacion de Ciencias Neurologicas de Nicaragua; Panamanian Society of Neurology & Neurosurgery; The Puerto Rican Academy of Neurology, Inc; American Academy of Neurology; Sociedad Neurologica Argentina; Sociedad Boliviana de Neurologia; Academia Brasileira de Neurologia; Sociedad de Neurologia, Psiquiatria y Neurocirugia, Chile; Asociacion Colombiana de Neurologia; Sociedad Ecuatoriana de Neurología;  Sociedad Paraguaya de Neurologia; Sociedad Peruana de Neurología;  Sociedad de Neurologia del Uruguay; Sociedad Venezolana de Neurologia


British Columbia Society of Electroneurophysiology Technologists; Alzheimer EuropeBritish Columbia Society of Electro Neurophysiology TechnologistsBritish Paediatric Neurology AssociationThe British Association of Stroke PhysiciansDanish Neurological SocietyDutch Society of NeurologyThe Association of British NeurologistsBritish Neuro-Oncology Society;Italian Neurological SocietyItalian Stroke SocietyBritish Acoustic Neuroma Association (BANA)(UK)British Neuropathological Society (BNS)Spanish Neurological Society; European Neurological Societies; British Neuro-Oncology Society; Spanish Society of Neurology; Romanian National Stroke Association; British Paediatric Neurology Association; British Association for Psychopharmacology; European Academy of Neurology; UK Parkinsons Action Network; European Neurological Society ; Albanian Society of Neurology; Armenian Association of Neurologists; Austrian Society of Neurology; Association of Azerbaijan Neurologists and Medical Geneticists; Belgian Neurological Society; Bulgarian Society of Neurology; Croatian Neurological Society;  Cyprus Neurological Society; Czech Society of Neurology;  Danish Neurological Society; Estonian Society of Neurologists & Neurosurgeons; Finnish Neurological Association; Société Française de Neurologie;  Georgian Society of Neurologists; Deutschen Gesellschaft für Neurologie e.V.;  Hellenic Association of Neurology; Hungarian Society of Neurology and Psychiatry;  Icelandic Neurological Society; Irish Institute of Clinical Neuroscience; Società Italiana di Neurologia; Latvian Neurologists Association; Lithuanian Neurological Society; Société Luxembourgeoise de Neurologie asbl; Macedonian Society of Neurology; Society of Neurologists of the Republic of Moldova; The Dutch Neurological Society; Norwegian Neurological Association; Polish Neurological Society; Sociedade Portuguesa de Neurologia; Romanian Neurological Society; All-Russian Society of Neurologists; Yugoslav Neurological Society; Slovak Neurological Society; Slovenian Society of Neurology; Sociedad Española de Neurologia; Swedish Neurological Society; Société Suisse de Neurologie; Turkish Neurological Society; Turkish Neurological Society


Algerian Society of Neurology and Clinical Neurophysiology; Societe Burkinabe de Neurologie;  Society of Cameroonian Neurologists; Société Ivoirienne de Neurologie; Egyptian Society of Neurology, Psychiatry & Neurosurgery; Association of Neurological Sciences of Ethiopia; Société Guinéenne De Neurologie; Neurological Society of Kenya;  Libyan Association of Psychiatry, Neurology and Neurosurgery; Société Mauritania de Neurologie; Moroccan Society of Neurology; Nigerian Society of Neurological Sciences; Senegalese Neurology Society (SNS) ; Neurological Association of South Africa; Sudanese Society for Neurological Sciences (SSNS); Tanzanian Neuroscience Association; Tunisian Society of Neurology; Uganda Neurology Association; The Neurological & Psychiatric Society of Zambia (NPSZ).

New Updates : Neurochemistry Congress 2018

Stroke increases among pregnant women in rare conditions: Neurochemistry Congress

Strokes caused by various reasons including a ruptured vessel on the brain's surface are increasingly being recognized among pregnant women. African-American women and those age 20-29 had the highest proportion of this rare stroke known as spontaneous subarachnoid hemorrhage.     

Spontaneous SAH is an abnormality in the brain's arteries that weaken and leads to ruptures in the blood vessels on the surface of the brain, causing bleeding between the membranes surrounding the brain. Spontaneous SAH refers to hemorrhage that occurs without trauma to the head or neck.

Information about sSAH in pregnant women is scarce. This study examined how often these strokes occur among both pregnant and non-pregnant women, and how the pregnant women fare at discharge from the hospital as a marker for outcomes.

In a review of records obtained for 3,978 pregnant women, age 15 to 49, from 2002 to 2014 researchers found:

After hospital admission, pregnant women with sSAH fared better than non-pregnant women with sSAH. Eight percent of pregnant women admitted to the hospital with stroke died, compared to 17 percent of non-pregnant women. Pregnant women also were more likely than non-pregnant women to be discharged from the hospital to home rather than to another medical facility.

"Pregnant women with spontaneous subarachnoid hemorrhage may have better outcomes than previously expected, which challenges prior findings from small,

The data came from the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample -- a national database that provides estimates of patients' hospital stays. However, the database does not provide information about the severity of the stroke. Another limitation of the findings is the possibility that the database included cases incorrectly classified as a stroke.



Drugs build their effects notable by acting to boost or interfere with the activity of neurotransmitters and receptors at intervals the synapses of the brain. Some neurotransmitters carry repressing messages across the synapses, whereas others carry excitant messages. Agonistic medicine enhance the message carried by the neurotransmitters; repressing neurotransmitters become a lot of repressing, and excitant neurotransmitters become a lot of excitant. Antagonistic medicine, on the opposite hand, interferes with the transmission of neurochemical messages; the action of neurotransmitters is interfered with so their effects area unit lessened or eliminated.

There area unit some ways that a drug will act to boost (Agonize) a given neurotransmitter:

An agonistic drug will spur hyperbolic production of explicit neurotransmitters. once those neurotransmitters area unit then free into the junction, they're a lot of varied than they'd commonly be, and a lot of of the neurochemical substances realize their far more than to the post-synaptic receptors on the dendrites of consecutive vegetative cell.

An agonistic drug will interfere with the re-uptake of neurochemical substances that has the impact of forcing them to stay within the junction and interacting with receptors longer than traditional (Cocaine effects the {norepinephrine|noradrenaline|catecholamine|monoamine neurochemical|vasoconstrictor|vasoconstrictive} and monoamine neurotransmitter neurotransmitter systems in exactly this way).

An agonistic drug will bypass the neurochemical entirely, and easily float out into the junction and itself bind with and activate the neurotransmitter's receptors.

Similarly, there area unit some ways that a drug will act to interfere with (Antagonize) a given neurotransmitter:

An antagonistic drug will interfere with the discharge of neurotransmitters into the junction.

An antagonistic drug will contend with the neurochemical for binding to the neurotransmitter's receptor. The antagonistic drug binds to the receptor, however, doesn't activate it, therefore interference receptors from being activated by the neurochemical.

An antagonistic drug will causes neurotransmitters to break of their containers within the terminal button, into the fluid of the pre-synaptic vegetative cell itself, creating the neurochemical substance inaccessible for unharness into the junction. once the vegetative cell is activated, there's less neurochemical on the market to be free into the junction.

Most of the medicine that get abused area unit agonists of assorted neurotransmitters - they work to boost the natural impact of neurotransmitters.

Mechanisms Of Specific Drug Activity:

Depressant Drugs:

Alcohol, Benzodiazepines, Barbiturates and different central systema nervosum depressant medicine act totally on a neurochemical substance referred to as aminoalkanoic acid (Gamma Aminobutyric Acid). aminoalkanoic acid is associate repressing neurochemical that produces different neurons less seemingly to activate. The depressant medicine area unit aminoalkanoic acid agonists, acting to assist aminoalkanoic acid cut back neural activation a lot of expeditiously than it always would. Alcohol additionally inhibits (acts as associate antagonist against) another excitant neurochemical (Glutamate), creating it tougher for salt to induce the systema nervosum excited.

Stimulant medicine:

Amphetamines have their primary effects on the neurochemical monoamine neurotransmitter. Amphetamines each induce the terminal button of monoamine neurotransmitter-producing neurons to let a lot of Dopamine out than traditional, and additionally keep that monoamine neurotransmitter call at the junction longer than it commonly would be allowed to remain. stimulant additionally acts agonistically on receptors for a unique neurochemical, vasoconstrictor, by competitory with vasoconstrictor for post-synaptic receptors and turning those post-synaptic receptors on.

Cocaine has its major impact by interference the re-uptake of the neurotransmitters monoamine neurotransmitter and monoamine neurotransmitter.

Opioid Drugs:

Opioid medicine bind to special neurochemical receptors within the brain (the 'mu', 'kappa', 'sigma' 'delta' and 'gamma' receptors) that have to be compelled to do with pain

Drugs treated as opioid narcotic antagonist competes with the opioids for his or her receptor sites, however isn't itself capable of activating those receptor sites. associate opioid addict on {naltrexone|narcotic associatetagonist} is therefore rendered a lot of or less incapable of obtaining high from their opioid drug of choice; they'll take an opioid, however it'll be blocked from the opioid receptors by the narcotic antagonist, and cannot have its impact.


Marijuana incorporates a complicated set of effects. It acts on the neurotransmitters monoamine neurotransmitter, monoamine neurotransmitter and neurotransmitter. It additionally binds to a receptor for a recently discovered neurochemical referred to as Anadamide.

Hallucinogens:  LSD is understood to antagonize monoamine neurotransmitter by interference it's unharness.


A chemical that is made by nerve cells and used to communicate with other cells, including other nerve cells and muscle cells.

Everything we do relies on neurons communicating with one another. Electrical impulses and chemical signals carrying messages across different parts of the brain and between the brain and the rest of the nervous system. 

When a neuron is activated a small difference in electrical charge occurs. This unbalanced charge is called an action potential and is caused by the concentration of ions (atoms or molecules with unbalanced charges) across the cell membrane. The action potential travels very quickly along the axon, like when a line of dominoes falls. 

When the action potential reaches the end of an axon, most neurons release a chemical message (a neurotransmitter) which crosses the synapse and binds to receptors on the receiving neuron's dendrites and starts the process over again. At the end of the line, a neurotransmitter may stimulate a different kind of cell (like a gland cell), or may trigger a new chain of messages. 

Neurotransmitters send chemical messages between neurons. Mental illnesses, such as depression, can occur when this process does not work correctly. Communication between neurons can also be electrical, such as in areas of the brain that control movement. When electrical signals are abnormal, they can cause tremors or symptoms found in Parkinson's disease

What causes a neurotransmitter imbalance

Drawn out times of pressure can drain neurotransmitters levels. Our quick paced, fast food society enormously adds to these irregular characteristics. 
Horrible eating routine. Neurotransmitters are made in the body from proteins. Likewise required are sure vitamins and minerals called "cofactors". On the off chance that your nourishment is poor and you don't take in enough protein, vitamins, or minerals to assemble the neurotransmitters, a neurotransmitter lopsidedness creates. We truly do think and feel what we eat. 
Hereditary components, flawed digestion, and stomach related problems can hinder assimilation and breakdown of our nourishment which diminishes are capacities to construct neurotransmitters. 
Harmful substances like overwhelming metals, pesticides, medication and liquor utilize, and some professionally prescribed medications can make lasting harm the nerve cells that make neurotransmitters. 
Certain medications and substances, for example, caffeine, liquor, nicotine, NutraSweet, antidepressants, and some cholesterol bringing down prescriptions drain neurotransmitter levels prompting neurotransmitter uneven characters. 
Hormone changes, for example, thyroid, adrenal, male and female sex hormones, can cause neurotransmitter lopsided characteristics. 
Medicinal conditions, for example, sustenance and compound hypersensitivity, glucose awkwardness, fiery conditions, GI issue, and head damage.

Past Conference Report

The 7th Global Experts Meeting on Neuropharmacology, hosted by the Conference Series LLC was held during July 31- August 02, 2017 at Hilton Garden Inn Milan North, Milan, Italy  Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Neuropharmacology, who made this event a grand success.

Know more at Neuropharmacology 2017 Proceedings

we expresses our gratitude to the conference Moderators, namely Dr. Jong Eun Lee, Dr. Mariya Hristova and Dr. Maha Nada for taking up the responsibility to co-ordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

We are grateful to our Spekaers of Special session. The list comprises:

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Neuro Immune Pharmacology
  • Molecular Neuropharmacology
  • Psychopharmacology
  • Neurochemical Transmission
  • Behavioral Neuropharmacology
  • Neurotechnology
  • Neuroendocrinology
  • Alzheimer’s Disease and Dementia
  • Parkinson’s Disease
  • Neuroethics
  • Future Aspects of Neuropharmacology
  • Clinical Neuropharmacology
  • Chemical Neurotransmitters
  • Case Study Reports
  • Entrepreneurs Investment Meet

We offer our   heartfelt appreciation to organizations such as Bentham Science and our esteemed supporters SelectScience Trade Show Alerts  Medgenera CrowdReviews PBR Clinical Biometrics Bio-Equip Nanobay Pharma Focus Asia ManuscriptEdit Times International eindiabusiness  and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. We also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Neuropharmacology 2017, We are proud to announce the 25th International Conference on Neurochemistry and Neuropharmacology " to be held during September 17-18, 2018 in Dubai, UAE.

To Collaborate Scientific Professionals around the World

Conference Date September 17-18, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Neurochemistry & Neuropharmacology Journal of Neurology & Neurophysiology Journal of Neurology and Neuroscience

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner




Media Partner




Media Partner


Media Partner








Media Partner


Media Partner












  • Axon And Dendrite Development
  • Behavioral Genetics
  • Behavioral Neuroscience
  • Blood-brain Barrier Disruption (BBB)
  • Brain Diseases
  • Brain Metastasis
  • Cell Body
  • Cell Lineage
  • Cell Migration
  • Chemical Synapse
  • Chronic Pain Management
  • Clinical Neurophysiology
  • CNS
  • CNS Pharmacology
  • Cognitive Function
  • Cognitive Psychology
  • Cranial Nerves
  • Dementia, Movement Disorders,
  • Dendrites
  • Developmental Neurorehabilitation
  • Dopamine
  • Drug Discovery
  • Electrodiagnostic Medicine
  • Endogenous Chemicals
  • Epilepsy
  • G Protein-coupled Receptors
  • GABA
  • Glioneuronal Tumors
  • Glutamate Neurotransmission
  • GPCR Signaling
  • Headaches
  • Hemorrhagic
  • Interventional Neurology
  • Intracranial Pressure
  • Long-Term Potentiation
  • Mechanisms Of Cell Fate
  • Memory Loss
  • Molecular Neuropharmacology
  • Molecular Neuroscience
  • Multiple Sclerosis
  • Muscular System
  • Nerve Terminal
  • Nervous System
  • Neuro
  • Neuroanatomy
  • Neurobiology
  • Neurobiology And Brain Physiology
  • Neurochemistry
  • Neurodegeneration
  • Neurodegenerative Diseases
  • Neuroendocrinology
  • Neurogenesis
  • Neuroimaging
  • Neuroimmunology
  • Neurointensive Care
  • Neuromelanin
  • Neuromodulation
  • Neuron-Glia Interaction
  • Neuronal Differentiation
  • Neuropeptide
  • Neuropeptidergic
  • Neuropharmacology
  • Neurophysiology
  • Neurophysiology)
  • Neuroplasticity Or Synaptic Plasticity
  • Neuroprotection
  • Neuroproteomics
  • Neuropsychiatric Disorders
  • Neuropsychiatry
  • Neuropsychopharmacology
  • Neuroscience
  • Neurotechnology
  • Neurotransmission
  • Neurotransmitter
  • Neurotransmitter Receptors
  • Neurotrophic Factors
  • Neurotrophin Electrophysiology
  • Opioid Peptides
  • Pain Medicine
  • Palliative And Terminal Care
  • Patch Clamp Recording
  • Peptidomics
  • Pharmacy
  • Postnatal Neurogenesis
  • Psychoneuroimmunology
  • Retrograde Neurotransmission
  • Rodent Stereotaxic Surgery
  • Serotonin Precursors
  • Signal Transduction
  • Signaling Cascades
  • Skull Metastasis
  • Sleep Disorders
  • Spinal Metastasis
  • Stereotaxic Surgery
  • Structure-activity Relationship
  • Sugrical Neurology
  • Synaptic Plasticity
  • Synaptic Vesicles
  • Systems Neuroscience
  • Vision Science